Home › Companies › MIRUM PHARMACEUTICALS INC. › 2023-2024
Compiled from SEC Form N-PX filings and MIRUM PHARMACEUTICALS INC.’s Form 8-K, filed 2024-06-06 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore MIRUM PHARMACEUTICALS INC. in the interactive database Compare manager voting policies
These tallies are MIRUM PHARMACEUTICALS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-06 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Laurent Fischer, M.D. | 19,162,293 | -- | -- | 14,762,966 | 3,790,601 | Majority: yes |
| Elect Director: Patrick Heron | 24,363,371 | -- | -- | 9,561,888 | 3,790,601 | Majority: yes |
| Elect Director: Saira Ramasastry, MS, M.Phil. | 25,853,444 | -- | -- | 8,071,815 | 3,790,601 | Majority: yes |
| Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors (the "Board") of Ernst & Young LLP as th | 37,536,300 | 36,362 | 143,198 | -- | -- | Majority: yes |
| Proposal 3. Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement for the Annual Meeting. | 32,709,274 | 1,125,532 | 90,453 | -- | 3,790,601 | Majority: yes |
Source: MIRUM PHARMACEUTICALS INC., Form 8-K, filed with the SEC on 2024-06-06 — read the filing on EDGAR.
Each item below shows how the 190 asset managers that disclosed a MIRUM PHARMACEUTICALS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MIRUM PHARMACEUTICALS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 10 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
MIRUM PHARMACEUTICALS INC.’s own tally for this item (“Proposal 3. Advisory Vote on Executive Compensation The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement for the Annual”): 32,709,274 for, 1,125,532 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,061,106 outstanding shares: 70% for, 2% against (72% of the company cast a for/against vote).
The 189 asset managers below cast 98% of the shares they voted on this item FOR (33,119,697 for, 560,870 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BVF INC/IL | 4,370,024 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 3,321,775 | 0 | 0 | 0 | For |
| State Street | 2,987,246 | 6,415 | 0 | 0 | For |
| T. Rowe Price | 2,611,343 | 0 | 0 | 0 | For |
| Janus Henderson | 2,250,125 | 0 | 0 | 0 | For |
| Vanguard | 2,093,901 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 1,858,864 | 0 | 0 | 0 | For |
| Novo Holdings A/S | 1,500,000 | 0 | 0 | 0 | For |
| BlackRock | 1,336,863 | 2,856 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 938,881 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 934,528 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 832,798 | 0 | 0 | 0 | For |
| Citadel | 751,669 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 625,000 | 0 | 0 | 0 | For |
| Charles Schwab | 543,606 | 0 | 0 | 0 | For |
| BOONE CAPITAL MANAGEMENT LLC | 451,898 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 438,412 | 0 | 0 | 0 | For |
| Invesco | 374,474 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 312,590 | 0 | 0 | 0 | For |
| Woodline Partners LP | 289,862 | 0 | 0 | 0 | For |
| Nuveen | 284,067 | 0 | 0 | 0 | For |
| TIAA | 282,182 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 249,306 | 0 | 0 | 0 | For |
| Aberdeen | 0 | 219,516 | 0 | 0 | Against |
| Altium Capital Management LP | 208,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 189 asset managers. See all 189 in the interactive database.
Combines 7 wordings of this item as funds reported it.
99.9% fund support · no official result
The 183 asset managers below cast 99.9% of the shares they voted on this item FOR (3,564,735 for, 36 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BVF INC/IL | 0 | 0 | 0 | 0 | 1-Yr |
| MUTUAL FUND SERIES TRUST | 3,321,775 | 0 | 0 | 0 | For |
| State Street | 0 | 0 | 0 | 0 | One Year |
| T. Rowe Price | 0 | 0 | 0 | 0 | One Year |
| Janus Henderson | 0 | 0 | 0 | 0 | One Year |
| Vanguard | 0 | 0 | 0 | 0 | One Year |
| Rock Springs Capital Management LP | 0 | 0 | 0 | 0 | One Year |
| Novo Holdings A/S | 0 | 0 | 0 | 0 | One Year |
| BlackRock | 0 | 0 | 0 | 0 | One Year |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | One Year |
| JANUS INVESTMENT FUND | 0 | 0 | 0 | 0 | One Year |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | One Year |
| Citadel | 0 | 0 | 0 | 0 | One Year |
| Polar Capital Holdings Plc | 0 | 0 | 0 | 0 | One Year |
| Charles Schwab | 0 | 0 | 0 | 0 | 1 Year |
| BOONE CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | 1 Year |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 0 | 0 | 0 | 0 | One Year |
| Invesco | 0 | 0 | 0 | 0 | One Year |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | One Year |
| Woodline Partners LP | 0 | 0 | 0 | 0 | One Year |
| Nuveen | 0 | 0 | 0 | 0 | One Year |
| TIAA | 0 | 0 | 0 | 0 | One Year |
| Clearbridge Investments, LLC | 0 | 0 | 0 | 0 | One Year |
| Aberdeen | 0 | 0 | 0 | 0 | One Year |
| Altium Capital Management LP | 208,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 183 asset managers. See all 183 in the interactive database.
Combines 7 wordings of this item as funds reported it.
56% Majority: yes · of votes cast
MIRUM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Laurent Fischer, M.D.”): 19,162,293 for, 14,762,966 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,061,106 outstanding shares: 41% for, 31% withheld (72% of the company cast a for/withheld vote).
The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (4,649,870 for, 1,204 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 3,321,775 | 0 | 0 | 0 | For |
| Vanguard | 0 | 0 | 2,018,704 | 0 | Abstain |
| State Street | 14,199 | 0 | 1,291,909 | 0 | Abstain |
| T. Rowe Price | 0 | 0 | 1,126,781 | 0 | Abstain |
| JANUS INVESTMENT FUND | 304,299 | 0 | 630,229 | 0 | Abstain |
| BlackRock | 0 | 0 | 537,500 | 0 | Abstain |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 312,590 | 0 | Abstain |
| TIAA | 282,182 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 271,803 | 0 | Abstain |
| Altium Capital Management LP | 208,000 | 0 | 0 | 0 | For |
| Legg Mason | 207,193 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 0 | 0 | 200,030 | 0 | Abstain |
| Invesco | 182,863 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 147,352 | 0 | Abstain |
| Aberdeen | 0 | 0 | 109,758 | 0 | Abstain |
| Equitable | 0 | 0 | 72,945 | 0 | Abstain |
| Advisors' Inner Circle Fund III | 46,995 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 46,443 | 0 | Abstain |
| SEI | 0 | 0 | 45,609 | 0 | Abstain |
| Fidelity | 25,785 | 0 | 15,024 | 0 | For |
| Tema ETF Trust | 28,260 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 26,509 | 0 | Abstain |
| John Hancock | 0 | 0 | 25,694 | 0 | Abstain |
| Northern Trust | 0 | 0 | 23,878 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 21,524 | 0 | Abstain |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 9 wordings of this item as funds reported it.
72% Majority: yes · of votes cast
MIRUM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Patrick Heron”): 24,363,371 for, 9,561,888 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,061,106 outstanding shares: 51.8% for, 20% withheld (72% of the company cast a for/withheld vote).
The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (8,500,082 for, 1,204 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 3,321,775 | 0 | 0 | 0 | For |
| Vanguard | 2,018,704 | 0 | 0 | 0 | For |
| State Street | 14,199 | 0 | 1,291,909 | 0 | Abstain |
| T. Rowe Price | 1,126,781 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 304,299 | 0 | 630,229 | 0 | Abstain |
| BlackRock | 0 | 0 | 537,500 | 0 | Abstain |
| FRANKLIN STRATEGIC SERIES | 312,590 | 0 | 0 | 0 | For |
| TIAA | 282,182 | 0 | 0 | 0 | For |
| Charles Schwab | 271,803 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 208,000 | 0 | 0 | 0 | For |
| Legg Mason | 207,193 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 0 | 0 | 200,030 | 0 | Abstain |
| Invesco | 182,863 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 147,352 | 0 | Abstain |
| Aberdeen | 0 | 0 | 109,758 | 0 | Abstain |
| Equitable | 5,468 | 0 | 67,477 | 0 | Abstain |
| Advisors' Inner Circle Fund III | 46,995 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 46,443 | 0 | Abstain |
| SEI | 45,609 | 0 | 0 | 0 | For |
| Fidelity | 25,785 | 0 | 15,024 | 0 | For |
| Tema ETF Trust | 28,260 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 26,509 | 0 | Abstain |
| John Hancock | 16,063 | 0 | 9,631 | 0 | For |
| Northern Trust | 0 | 0 | 23,878 | 0 | Abstain |
| ALPS ETF Trust | 0 | 0 | 21,524 | 0 | Abstain |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 8 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
MIRUM PHARMACEUTICALS INC.’s own tally for this item (“Elect Director: Saira Ramasastry, MS, M.Phil.”): 25,853,444 for, 8,071,815 withheld, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,061,106 outstanding shares: 54.9% for, 17% withheld (72% of the company cast a for/withheld vote).
The 58 asset managers below cast 99.9% of the shares they voted on this item FOR (9,760,631 for, 1,204 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 3,321,775 | 0 | 0 | 0 | For |
| Vanguard | 2,018,704 | 0 | 0 | 0 | For |
| State Street | 1,287,006 | 0 | 19,102 | 0 | For |
| T. Rowe Price | 1,126,781 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 304,299 | 0 | 630,229 | 0 | Abstain |
| BlackRock | 537,500 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 312,590 | 0 | Abstain |
| TIAA | 282,182 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 271,803 | 0 | Abstain |
| Altium Capital Management LP | 208,000 | 0 | 0 | 0 | For |
| Legg Mason | 207,193 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 0 | 0 | 200,030 | 0 | Abstain |
| Invesco | 182,863 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 0 | 0 | 147,352 | 0 | Abstain |
| Aberdeen | 0 | 0 | 109,758 | 0 | Abstain |
| Equitable | 48,845 | 0 | 24,100 | 0 | For |
| Advisors' Inner Circle Fund III | 46,995 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 46,443 | 0 | Abstain |
| SEI | 0 | 0 | 45,609 | 0 | Abstain |
| Fidelity | 40,809 | 0 | 0 | 0 | For |
| Tema ETF Trust | 28,260 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 26,509 | 0 | Abstain |
| John Hancock | 16,063 | 0 | 9,631 | 0 | For |
| Northern Trust | 23,878 | 0 | 0 | 0 | For |
| ALPS ETF Trust | 0 | 0 | 21,524 | 0 | Abstain |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
MIRUM PHARMACEUTICALS INC.’s own tally for this item (“Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors (the "Board") of Ern”): 37,536,300 for, 36,362 against, per its Form 8-K filed 2024-06-06 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 47,061,106 outstanding shares: 80% for, 0.1% against (80% of the company cast a for/against vote).
The 58 asset managers below cast 100% of the shares they voted on this item FOR (11,881,702 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| MUTUAL FUND SERIES TRUST | 3,321,775 | 0 | 0 | 0 | For |
| Vanguard | 2,018,704 | 0 | 0 | 0 | For |
| State Street | 1,306,108 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,126,781 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 934,528 | 0 | 0 | 0 | For |
| BlackRock | 537,500 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 312,590 | 0 | 0 | 0 | For |
| TIAA | 282,182 | 0 | 0 | 0 | For |
| Charles Schwab | 271,803 | 0 | 0 | 0 | For |
| Altium Capital Management LP | 208,000 | 0 | 0 | 0 | For |
| Legg Mason | 207,193 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 200,030 | 0 | 0 | 0 | For |
| Invesco | 182,863 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 147,352 | 0 | 0 | 0 | For |
| RWC Asset Management LLP | 143,513 | 0 | 0 | 0 | For |
| Aberdeen | 109,758 | 0 | 0 | 0 | For |
| Equitable | 72,945 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 46,995 | 0 | 0 | 0 | For |
| ProShares | 46,443 | 0 | 0 | 0 | For |
| SEI | 45,609 | 0 | 0 | 0 | For |
| Fidelity | 40,809 | 0 | 0 | 0 | For |
| Tema ETF Trust | 28,260 | 0 | 0 | 0 | For |
| First Trust | 26,509 | 0 | 0 | 0 | For |
| John Hancock | 25,694 | 0 | 0 | 0 | For |
| Northern Trust | 23,878 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. See all 58 in the interactive database.
100% fund support · no official result
The 4 asset managers below cast 100% of the shares they voted on this item FOR (7,352 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JPMorgan | 0 | 0 | 0 | 0 | One Year |
| Desjardins Global Asset Management Inc. | 0 | 0 | 0 | 0 | One Year |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 0 | 0 | 0 | 0 | 1-Year |
| RWC Asset Management LLP | 7,352 | 0 | 0 | 0 | For |
— fund support · no official result
No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Simplify Exchange Traded Funds | 0 | 0 | 70,000 | 0 | Abstain |
| Granite Investment Partners, LLC | 0 | 0 | 0 | 0 | 1 Year |
Ranked by the number of MIRUM PHARMACEUTICALS INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 47,061,106 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BVF INC/IL | 9.29% |
| 2 | MUTUAL FUND SERIES TRUST | 7.06% |
| 3 | State Street | 6.36% |
| 4 | T. Rowe Price | 5.55% |
| 5 | Janus Henderson | 4.78% |
| 6 | Vanguard | 4.45% |
| 7 | Rock Springs Capital Management LP | 3.95% |
| 8 | Novo Holdings A/S | 3.19% |
| 9 | BlackRock | 2.85% |
| 10 | FRANKLIN ADVISERS INC | 2.00% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Patrick Heron | 13.91% | DEF14A |
| Frazier Life Sciences IX, L.P. | 13.80% | DEF14A |
| Biotechnology Value Fund, L.P. | 9.29% | DEF14A |
| BlackRock | 7.65% | 13F |
| State Street | 6.00% | 13F |
| Eventide Asset Management, LLC | 5.72% | DEF14A |
| Vanguard Group | 5.41% | 13F |
| T. Rowe Price | 3.39% | 13F |
| Christopher Peetz | 3.11% | DEF14A |
| Citadel Advisors | 3.04% | 13F |
Percentages above are of 47,061,106 shares outstanding, as reported by MIRUM PHARMACEUTICALS INC. on its Form 10-Q dated 2024-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MIRUM PHARMACEUTICALS INC.’s 10-Q dated 2024-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At MIRUM PHARMACEUTICALS INC.'s shareholder meeting held 2024-06-05, in the 2023-2024 proxy season, 190 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,365 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of the Company's named executive officers… — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MIRUM PHARMACEUTICALS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-06.
MIRUM PHARMACEUTICALS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.